510(k) Report

510(k) · Cleared

Cleared

Galileo Endoscopes

K934649510(k) TraditionalCleared Oct 13, 1994379-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Galileo Electro-Optics Corp. · FBO Cystourethroscope

Cleared on Oct 13, 1994 after a 379-day review. FDA has not posted a summary or statement for it, so its predicates are not known.

Decided
Oct 13, 1994
Review
379 days
Class
Class II
Product code
FBO
Recalls
None
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K934649Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FBO device

  1. #1 K244001 KARL STORZ Cysto-Urethro-Fiberscope…score 9.3 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All FBO devices

FBO Cystourethroscope: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FBO

1in 2025

2007: 12008: 22014: 12024: 12025: 1
2007high 2 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FBO

Too few FBO 510(k)s in any year since 2007 to give a median.

Recalls per year · FBO

1in 2023

2022: 52023: 1
2007high 5 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FBO

26in 2025

2008: 32009: 22010: 32011: 32012: 72013: 52014: 102015: 102016: 92017: 112018: 112019: 152020: 202021: 182022: 332023: 292024: 302025: 26
2007high 33 (2022) · low 0 (2007)2025

MAUDE reports naming product code FBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—03
20090—02
20100—03
20110—03
20120—07
20130—05
20141—010
20150—010
20160—09
20170—011
20180—011
20190—015
20200—020
20210—018
20220—533
20230—129
20241—030
20251—026
20260—0—
Cite this page

510(k) Report. “K934649: Galileo Endoscopes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K934649

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026